Back
Jeronimo Martins SGPS SA Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
34
JRONY
Jeronimo Martins SGPS SA
Last Price:
39.15
Seasonality Move:
0.75%
Buy
51
ALNY
Alnylam Pharmaceuticals
Last Price:
242.97
Seasonality Move:
20.36%
Sell
34
Jeronimo Martins SGPS SA (JRONY)
is a Sell
Is Jeronimo Martins SGPS SA a Buy, Sell or Hold?
- The current Jeronimo Martins SGPS SA [JRONY] share price is $39.67. The Score for JRONY is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- JRONY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $247.00. The Score for ALNY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JRONY Stock Price Chart
What is Jeronimo Martins SGPS SA's stock price today?
-
The Jeronimo Martins SGPS SA share price today is $39.67
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JRONY is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $247.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.
JRONY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.69 | Sell |
Relative Strength Index (14 RSI): | 33.15 | Sell |
Chaikin Money Flow: | 4964 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.51 - 44.59) | Sell |
Bollinger Bands (100): | (40.01 - 45.91) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 20.83 | Buy |
Relative Strength Index (14 RSI): | 90.67 | Buy |
Chaikin Money Flow: | -365678 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (135.21 - 198.95) | Buy |
Bollinger Bands (100): | (137.63 - 173.99) | Buy |
JRONY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.38 | Sell |
20-day SMA: | 42.67 | Sell |
50-day SMA: | 42.44 | Sell |
200-day SMA: | 44.99 | Sell |
8-day EMA: | 41.2 | Sell |
20-day EMA: | 42.15 | Sell |
50-day EMA: | 42.57 | Sell |
200-day EMA: | 44.66 | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 198.72 | Buy |
20-day SMA: | 171.59 | Buy |
50-day SMA: | 157.67 | Buy |
200-day SMA: | 165.81 | Buy |
8-day EMA: | 210.85 | Buy |
20-day EMA: | 183.04 | Buy |
50-day EMA: | 165.87 | Buy |
200-day EMA: | 167.34 | Buy |
Jeronimo Martins SGPS SA Earnings Growth & JRONY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.46 per share, and an increase next year of $1.83 per share.
Jeronimo Martins SGPS SA Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |